Costs-effectiveness and cost components of pharmaceutical and non-pharmaceutical interventions affecting antibiotic resistance outcomes in hospital patients: a systematic literature review
Article in BMJ Global Health (February 2024)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Cost-effectiveness analysis of ceftazidime-avibactam as definitive treatment for treatment of carbapenem-resistant Klebsiella pneumoniae bloodstream infection
Article in Frontiers in Public Health (February 2023)
Meropenem/vaborbactam cost effective in Italy
Article in PharmacoEconomics & Outcomes News (November 2021)